This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Several studies assessed the effect of deep brain stimulation (DBS) of the subthalamic nucleus (STN) on restless legs syndrome (RLS) symptoms in patients with Parkinson disease (PD) with conflicting results.1–5 As underlined by Klepitskaya et al.,1 one crucial variable is dopaminergic therapy, as emergence of RLS after STN DBS in patients with PD has been reported after abrupt decrease of dopaminergic treatment.3 Klepitskaya et al. argued that, in a previous study we conducted,5 patients with emergence of RLS after STN DBS took a higher dose and had a more significant reduction of dopamine agonists compared to those without emergence with RLS. Yet, we actually reported the opposite, showing an emergence of RLS in patients with PD with a higher dose of dopamine agonists postoperatively and with a lesser decrease of dopamine agonists after STN DBS.5
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.